TERT and cancer: Telomerase activity is a hallmark of many cancers, and two other genetic mechanisms of TERT reactivation have been described recently; both somatic mutations in the promoter of the TERT gene48 and DNA copy number gains of TERT49 were shown to activate its transcription.